Dr. Kshitij Domadiya
Consultant - Medical Oncologist
- OPD Timing
- Mon to Sat : By Appointment Only
Educational Qualifications
- MBBS, MD (Internal Medicine), DNB (Medical Oncology), ECMO
Speciality
Hemato Oncology
Special Interest
- Bariatric Surgery: Specializes in weight loss surgery to treat obesity and related health issues.
- Gastrointestinal Surgery: Expertise in advanced gastrointestinal and onco-colorectal surgeries.
- Metabolic Surgery: Focus on addressing metabolic disorders associated with obesity.
- Research and Education: Actively involved in research and training programs for fellow surgeons.
- Patient Support and Awareness: Engages in activities to promote awareness about obesity and provides personalized patient care.
Experience
- 8 years of experience
Awards
- Dr. Kshitij has won ‘Molecular oncology grant competition’ on a research project on liquid biopsy in lung cancer at ICON Conference 2018.
- He has also secured a scholarship grant at ‘SPEAK’ BREAST CANCER conference, Mumbai in 2018.
Research And Publications
- Dr. Kshitij has many publications to his name in both reputed national and international journals. He is an invited speaker at many national conference:
- Only 9 weeks or complete 12 months of adjuvant trastuzumab in Indian early-stage breast cancer patients: Is it the practice-changing approach in a resource-constrained setting?. Cancer Research, Statistics, and Treatment. 2020 Jul 1;3(2):401.
- Study of efficacy and tolerability of paclitaxel and carboplatin as a concurrent chemotherapeutic radiation sensitizer regimen in patients of esophageal cancer: Prospective observational study from a tertiary centre in northern India. DOI: 10.1200/JCO.2020.38.15_suppl.e16526 Journal of Clinical Oncology 38, no. 15_suppl
- Real-World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Tertiary Care Cancer Center in India. International Journal of Molecular & Immuno Oncology. 2019 Sep 14;4(3):63-6.
- Good response to erlotinib in a patient after progression on osimertinib: A rare case of spatiotemporal T790M heterogeneity in a patient with epidermal growth factor receptor-mutant nonsmall cell lung cancer. South Asian Journal of Cancer. 2017 Oct;6(4):179. Retrospective Evaluation of PD-L1 Expression in Tumour Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographical Data from a Tertiary Care Institute of Northern India. (Poster at ESMO Asia Singapore 2018)
- Clinical-Epidemiological Profile of Influenza A H1N1 Cases at a Tertiary Care Institute of Western India. Indian Journal of Applied Research, Vol.5, Issue: 10 October 2015
- Presented E-Poster at IBCC, Jaipur 2017 -“A Study of Clinico-Pathological Profile of Basal & Non-Basal Subtype of Triple Negative Breast Cancer”
Membership
- European society of medical oncology